The days of sacrificing half a workday in a waiting room for 15 minutes of blood work seem to be fading. With the surge of direct-to-consumer options since 2020, diagnostic companies have exhibited remarkable creativity in expanding the range of indications addressed at home all while enhancing accuracy. This model not only improves access, but also has the potential to revolutionize disease detection. How will health systems adapt to accommodate these new patients, and will consumers take the initiative to connect with the appropriate specialists? This transition promises a more convenient and transparent system for blood work, genetic testing, and more, but not without scrutiny. Questions surrounding DIY diagnostic trends? reimbursement feasibility and potential for user error are casting a shadow over progress. Will D2C spaces become the primary hub for cutting-edge diagnostics? Will payers take more notice? Identifying existing frictions in the diagnostics space paves the way for potential disruptions in the near future. Let?s DIY our way to preventative health.